Mood - Anxiety Disorders & Antidepressants – Mood
Stabilizers
Response,
Partial Response, and Nonresponse in Primary Care
Treatment of Depression
Patricia K. Corey-Lisle, Rowena Nash, Paul Stang, Ralph Swindle
Arch
Intern Med. 2004;164:1197-1204
Increased Positive Versus
Negative Affective Perception and Memory in Healthy Volunteers Following
Selective Serotonin and Norepinephrine Reuptake
Inhibition
Catherine J. Harmer, Nicholas C. Shelley, Philip J. Cowen,
and Guy M. Goodwin
Am J Psychiatry 161:1256-1263, July 2004
The Mood Spectrum in Unipolar
and Bipolar Disorder: Arguments for a Unitary Approach
Giovanni B. Cassano, Paola Rucci, Ellen Frank, Andrea Fagiolini,
Liliana Dell’Osso, M.
Katherine Shear, and David J. Kupfer
Am J Psychiatry 161:1264-1269, July 2004
Elevated Neuron Number in the Limbic Thalamus in Major
Depression
Keith A. Young, Leigh A. Holcomb, Umar
Yazdani, Paul B. Hicks, and Dwight C. German
Am J Psychiatry 161:1270-1277, July 2004
Which Factors Influence Psychiatrists’ Selection of
Antidepressants?
Mark Zimmerman, Michael Posternak,
Michael Friedman, Naureen Attiullah,
Scott Baymiller, Robert Boland, Stacie Berlowitz, Shahzad Rahman, Kirsten Uy, and Steve
Singer
Am J Psychiatry 161:1285-1289, July 2004
Combat Duty in Iraq and Afghanistan, Mental Health
Problems, and Barriers to Care
Charles W. Hoge, Carl A.
Castro, Stephen C. Messer, Dennis McGurk, Dave I. Cotting, and Robert L. Koffman
NEJM. 2004; Volume 351:13-22
THE DEVELOPMENTAL ORIGINS OF ANXIETY
Cornelius Gross
& Rene Hen
Nature
Reviews Neuroscience 5, 545 -552 (2004)
Interaction of St John's wort with
conventional drugs: systematic review of clinical trials
Edward Mills, Victor M Montori,
, Ping Wu,
, Keith Gallicano, , Mike Clarke,
, Gordon Guyatt
BMJ 2004;329:27-30 (3 July)
Hippocampal volume, memory, and cortisol status in major
depressive disorder: effects of treatment
Meena Vythilingam,
Eric Vermetten, George M. Anderson, David Luckenbaugh, Eric R. Anderson, Joseph Snow, Lawrence H. Staib, Dennis S. Charney and J.
Douglas Bremner
Biological
Psychiatry. Volume 56, Issue 2 , 15 July 2004, Pages
101-112
Effect
of comorbid anxiety disorders on the
Hypothalamic-Pituitary-Adrenal axis response to a social stressor in major
depression
Elizabeth
A. Young, James L. Abelson and Oliver G. Cameron
Biological
Psychiatry. Volume 56, Issue 2 , 15 July 2004, Pages 113-120
Neuroimmune and cortisol changes in
selective serotonin reuptake inhibitor and placebo treatment of chronic
posttraumatic stress disorder
Phebe Tucker, William D. Ruwe,
Barbara Masters, Don E. Parker, Akm Hossain, Richard P. Trautman and
Dorothy B. Wyatt
Biological Psychiatry. Volume 56, Issue 2
, 15 July 2004, Pages 121-128
Clinical
Results for Patients With Major Depressive Disorder in
the Texas
Medication Algorithm Project
Madhukar H. Trivedi, A. John Rush, M.
Lynn Crismon, T. Michael Kashner,
Marcia G. Toprac, Thomas J. Carmody,
Tracie Key, Melanie M. Biggs, Kathy Shores-Wilson, Bradley Witte, Trisha Suppes, Alexander L. Miller, Kenneth Z. Altshuler,
Steven P. Shon
Arch Gen Psychiatry. 2004;61:669-680
Subtype-Specific
Alterations of Gamma-Aminobutyric Acid and Glutamate in Patients With Major Depression
Gerard Sanacora, Ralitza Gueorguieva, C. Neill Epperson, Yu-Te Wu, Michael Appel, Douglas L. Rothman, John H. Krystal,
Graeme F. Mason
Arch Gen Psychiatry. 2004;61:705-713
Combined
Pharmacotherapy and Psychological Treatment for Depression. A Systematic Review
Sandro Pampallona, Paola Bollini, Giuseppe Tibaldi, Bruce Kupelnick, Carmine Munizza
Arch Gen Psychiatry. 2004;61:714-719
Jesús Pujol, Carles Soriano-Mas, Pino Alonso, Narcís
Cardoner, José M. Menchón,
Joan Deus, Julio Vallejo
Arch Gen Psychiatry. 2004;61:720-730
Response to clozapine of rapid cycling versus non-cycling patients with
a history of mania
Suppes T, Ozcan ME, Carmody T
Bipolar Disord 2004: 6: 329-332
Treatment
emergent affective switch: a controlled study
Tamada RS, Issler CK, Amaral
JA, Sachs GS, Lafer B
Bipolar Disord 2004: 6: 333-337
A
Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine
Combination for Major Depression With Psychotic Features
Rothschild, Anthony J.; Williamson, Douglas J.; Tohen, Mauricio F.; Schatzberg,
Alan; Andersen, Scott W.; Van Campen, Luann E.;
Sanger, Todd M.; Tollefson, Gary D
Journal of Clinical Psychopharmacology. 24(4):365-373, August 2004
Effects on
Weight and Outcome of Long-term Olanzapine-Topiramate
Combination Treatment in Bipolar Disorder
Vieta,
Eduard; Sanchez-Moreno, Jose ; Goikolea,
Jose Manuel ; Colom, Francesc
; Martinez-Aran, Anabel; Benabarre, Antonio ; Corbella,
Barbara ; Torrent, Carla ; Comes, Merce ; Reinares, Maria ; Brugue, Esteve
Journal of Clinical Psychopharmacology. 24(4):374-378, August 2004
Testosterone
Versus Fluoxetine for Depression and Fatigue in
HIV/AIDS: A Placebo-Controlled Trial
Rabkin,
Judith G. ; Wagner, Glenn J. ; McElhiney, Martin C.; Rabkin, Richard ; Lin, Shu Hsing
Journal of Clinical Psychopharmacology.
24(4):379-385, August 2004
Comparing the
Effects of 8-Week Treatment With Fluoxetine and Imipramine on Fasting Blood Glucose of Patients With Major
Depressive Disorder
Ghaeli,
Padideh ; Shahsavand, Esmail ; Mesbahi, Mojdeh ; Kamkar, Mahammad-Zaman ; Sadeghi, Majid ; Dashti-Khavidaki, Simin
Journal of Clinical Psychopharmacology. 24(4):386-388, August 2004
Duloxetine in the Treatment of Depression: A Double-Blind
Placebo-Controlled Comparison With Paroxetine
Goldstein, David J. ; Lu, Yili ;
Detke, Michael J. ; Wiltse,
Curtis ; Mallinckrodt, Craig ; Demitrack, Mark A
Journal of Clinical Psychopharmacology. 24(4):389-399, August 2004
Effect of
Antidepressant Medication Resistance on Short-term Response to
Electroconvulsive Therapy
van den Broek, Walter W. ; de Lely, Ariejan ; Mulder, Paul G.H. ; Birkenhager,
Tom K. ; Bruijn, Jan A
Journal of Clinical Psychopharmacology. 24(4):400-403, August 2004
Vadim S. Rotenberg
Progress in Neuro-Psychopharmacology and Biological
Psychiatry. Volume 28, Issue 1, January
2004, Pages 1-13
Gender
differences in treatment response to sertraline
versus imipramine in patients with nonmelancholic depressive disorders
Enrique Baca,
Margarida Garcia-Garcia and Alberto Porras-Chavarino
Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 28, Issue 1, January 2004, Pages 57-65
Effects of
lithium and valproate on agonist-induced platelet
intracellular calcium mobilization: relevance to myosin light chain kinase
Katsuji Suzuki, Ichiro Kusumi, Tatsuyuki Akimoto, Yuki Sasaki and Tsukasa Koyama
Progress in Neuro-Psychopharmacology and Biological
Psychiatry. Volume 28, Issue 1 , January 2004, Pages
67-72
Sex- and
age-related differences in major depressive disorder with comorbid
anxiety treated with fluoxetine
P. Cassano, C. N. Soares, L.
S. Cohen, A. K. Lyster and M. Fava
Archives of Women's Mental Health 2004; Volume 7, Number
3: 167 - 171
The impact of
depression and fluoxetine treatment on obstetrical
outcome
R. Suri, L. Altshuler, V. Hendrick, N. Rasgon,
E. Lee and J. Mintz
Archives of Women's Mental Health 2004; Volume 7, Number
3: 193 - 200
Effects of citalopram on worry and brain activation in patients with
generalized anxiety disorder
Rudolf Hoehn-Saric, Michael W. Schlund
and Steven H. Y. Wong
Psychiatry Research: Neuroimaging.
Volume 131, Issue 1 , 30 May 2004, Pages 11-21
No
Deterioration of Cognitive Performance in an Aggressive Unilateral and
Bilateral Antidepressant rTMS Add-On Trial
Armand Hausmann, Alvaro Pascual-Leone,
Georg Kemmler,
Claudia I. Rupp, Theresia Lechner-Schoner,
Karin Kramer-Reinstadler, Michaela Walpoth, Sergei Mechtcheriakov, Andreas Conca,
and Elisabeth M. Weiss
J Clin Psychiatry 2004;65:772-782
Severity and Comorbidity Predict Episode Duration and Recurrence of
DSM-IV Major Depressive Disorder
Tarja K. Melartin, Heikki J. Rytsälä, Ulla S. Leskelä, Paula S. Lestelä-Mielonen, T. Petteri Sokero, and Erkki T. Isometsä
J Clin Psychiatry 2004;65:810-819
Alan C.
Swann, David G. Daniel, Lisa D. Kochan, Patricia J.
Wozniak, and Joseph R. Calabrese
J Clin Psychiatry 2004;65:825-829
Elie Lepkifker, Anna Sverdlik, Iulian Iancu, Reuven Ziv,
Shlomo Segev, and Moshe Kotler
J Clin Psychiatry 2004;65:850-856
Cardiac
adverse effects associated with psychotropic drugs
Schmid C,
Grohmann R, Engel RR, Ruther E, Kropp S
Pharmacopsychiatry 2004;37(SUPPL. 1):S65-S69
Antiepileptic
drugs: indications other than epilepsy
Spina E, Perugi
G
Epileptic Disord. 2004 Jun;6(2):57-75
Ariane
Marie-Mitchell, Andrew F. Leuchter, Chih-Ping Chou, W. James Gauderman
and Stanley P. Azen
Psychiatry Research. Volume 127, Issues 1-2 , 30
June 2004, Pages 73-84
Alessandro Serretti, Laura Mandelli, Enrico Lattuada and Enrico
Smeraldi
Psychiatry Research Volume 127, Issues 1-2 , 30 June 2004, Pages 85-99
Improvements
in Neurocognitive Function and Mood Following
Adjunctive Treatment with Mifepristone (RU-486) in
Bipolar Disorder
Allan H Young, Peter Gallagher, Stuart Watson, Dolores Del-Estal, Bruce M Owen and I Nicol
Ferrier
Neuropsychopharmacology (2004) 29, 1538-1545
Hershel Jick,
James A. Kaye, Susan S. Jick
JAMA. 2004;292:338-343
Ronald S. Duman
Biological Psychiatry Volume 56, Issue 3 ,
1 August 2004, Pages 140-145
Elizabeth A.
Young and Naomi Breslau
Biological Psychiatry Volume 56, Issue 3 ,
1 August 2004, Pages 205-209
Drug-induced
depression: A systematic review to inform clinical practice
Patten SB, Barbui C
Psychotherapy and Psychosomatics 2004;73(4):207-215
Emerging
experimental therapeutics for bipolar disorder: insights from the molecular and
cellular actions of current mood stabilizers
T D Gould, J
A Quiroz, J Singh, C A Zarate Jr
and H K Manji
Molecular Psychiatry (2004) 9, 734-755
Emerging
experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology
J
A Quiroz, J Singh, T D Gould, K D Denicoff, C A Zarate Jr and H K Manji
Molecular Psychiatry (2004) 9, 756-776
Therapeutic
drug monitoring of trazodone: are there
pharmacokinetic interactions involving citalopram and
fluoxetine?
Prapotnik M, Waschgler
R, Konig P, Moll W, Conca A
Int
J Clin Pharmacol Ther. 2004 Feb;42(2):120-4
Continuation
cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding
acutely to fluoxetine
Petersen T, Harley R, Papakostas GI, Montoya HD, Fava
M, Alpert JE
Psychol Med. 2004 Apr;34(3):555-61
Paroxetine in the
treatment of generalised anxiety disorder
Snyderman SH, Rynn
MA, Bellew K, Rickels K
Expert Opin Pharmacother. 2004 Aug;5(8):1799-806
Posttraumatic
stress disorder: acquisition, recognition, course, and treatment
Davidson JR, Stein DJ, Shalev AY, Yehuda R
J Neuropsychiatry Clin Neurosci. 2004 Spring;16(2):135-47
Citalopram as Treatment of Depression in Patients With Epilepsy
Specchio LM, Iudice
A, Specchio N, La Neve A, Spinelli A, Galli R, Rocchi R, Ulivelli M, De Tommaso M, Pizzanelli C, Murri L
Clin Neuropharmacol. 2004 May-Jun;27(3):133-136
Treatment and
response in refractory depression: results from a specialist affective
disorders service
Kennedy N, Paykel
ES
J Affect Disord. 2004 Jul;81(1):49-53
Reboxetine adjunct for
partial or nonresponders to antidepressant treatment
Rubio G, San L, Lopez-Munoz F,
Alamo C
J Affect Disord. 2004 Jul;81(1):67-72
Depression
and Late Mortality After Myocardial Infarction in the Enhancing Recovery in
Coronary Heart Disease (ENRICHD) Study
Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith
RC, Burg MM, Cornell C, Saab PG, Kaufmann PG, Czajkowski
SM, Jaffe AS
Psychosom Med. 2004 Jul-Aug;66(4):466-74
Clinical
response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol
levels: mini review
Reiji
Yoshimura, Jun Nakamura, Koji Shinkai and Nobuhisa Ueda
Progress in Neuro-Psychopharmacology and Biological
Psychiatry Volume 28, Issue 4 , July 2004, Pages 611-616
Extracellular serotonin, dopamine and glutamate levels are elevated
in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine
Katsutoshi Shioda, Koichi Nisijima, Tatsuki Yoshino and
Satoshi Kato
Progress in Neuro-Psychopharmacology and Biological PsychiatryVolume 28, Issue 4 , July 2004, Pages 633-640
Three year
naturalistic outcome study of panic disorder patients treated with paroxetine
Dannon PN, Iancu
I, Cohen A, Lowengrub K, Grunhaus
L, Kotler M
BMC Psychiatry. 2004 Jun 11;4(1):16
Efficacy and
tolerability of escitalopram in 12- and 24-week
treatment of social anxiety disorder: Randomised,
double-blind, placebo-controlled, fixed-dose study
Lader M, Stender
K, Burger V, Nil R
Depress Anxiety. 2004;19(4):241-8
Social
adjustment in generalised anxiety disorder: a
long-term placebo-controlled study of venlafaxine
extended release
Boyer P, Mahe
V V, Hackett D
Eur Psychiatry. 2004 Aug;19(5):272-279
.
Regresar a RESÚMENES JULIO 2004
